Product Information
GEMCITABINE HCL 1 GRAM VIAL is a generic product labeled by Hospira Inc., priced at $19.9960 per EA under NDC 00409018601. Its NADAC has been published 69 times since Oct 23, 2024.
Strength
38 mg/mL
Manufacturer
Hospira Inc.NDC
00409018601
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
2/19/2025
Active Ingredients
GEMCITABINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078339On Market Since
7/26/2011
Pharmacological Classes
Price Statistics
The NADAC for GEMCITABINE HCL 1 GRAM VIAL has been published 69 times since Oct 23, 2024, and over the history we have for it it has declined 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.9960 per EA |
|---|---|
| All-time high | $21.2267 (Dec 11, 2024) |
| All-time low | $19.9960 (Feb 19, 2025) |
| 52-week high | $19.9960 |
| 52-week low | $19.9960 |
| Median price | $19.9960 |
| Average price | $20.2338 |
| Largest weekly change | -3.0% (Feb 19, 2025) |
| Weeks tracked | 69 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the GEMCITABINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GEMCITABINE HCL 1 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for GEMCITABINE HCL 1 GRAM VIAL, manufactured by Hospira Inc., is $19.9960 per EA (NDC 00409018601), effective Feb 11, 2026.
How has the price of GEMCITABINE HCL 1 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for GEMCITABINE HCL 1 GRAM VIAL has declined 5.8%. It has been tracked across 69 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for GEMCITABINE HCL 1 GRAM VIAL?
Since Oct 23, 2024, the NADAC for GEMCITABINE HCL 1 GRAM VIAL has ranged from a low of $19.9960 (Feb 19, 2025) to a high of $21.2267 (Dec 11, 2024), with a median of $19.9960 per EA.
Are there cheaper alternatives to GEMCITABINE HCL 1 GRAM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GEMCITABINE HCL 1 GRAM VIAL, so no direct lower-cost alternative is listed.
Who manufactures GEMCITABINE HCL 1 GRAM VIAL?
GEMCITABINE HCL 1 GRAM VIAL (NDC 00409018601) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification